To IPO or not to IPO

To IPO or not to IPO, that is the question

pinehill | 2018-12-06

Are you an emerging biotech, pharma, medical device company thinking about going public in the next one to three years? Please join Pine Hill and Donnelley Financial on December 6th for a panel discussion on how to best prepare for and execute a successful IPO, as well as adjust to life post-IPO. Register here. 

Thursday, December 6, 2018

Life Sciences Pennsylvania

3:00PM-5:00PM - Conference
5:00PM-6:30PM - Victory Brewing - Beer & Wine Tasting + Food Pairings

Jeff Ammerman, Managing Director Healthcare Investment Banking, Piper Jaffray & Co.
Rachael Bushey, Partner, Pepper Hamilton
Roberto Cuco, Chief Financial Officer, OraSure
Thomas P. Hess, Chief Financial Officer, Genomind
Carolyn Saacke, COO of Capital Markets, NYSE
Steve Simpson, Partner, EY

Barbara Elias, Managing Director, Donnelley Financial Solutions
Dan Rudio, Managing Director, Pine Hill Group

mail icon